Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Country | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|
| RAMP | LIVERAMP HOLDINGS INC | United States | $2.16B | 66,183,731 | 55.37% | 44.63% | Net Selling | Net Selling |
| PRGO | PERRIGO CO PLC | Ireland | $4.33B | 135,515,939 | 61.54% | 38.46% | Net Selling | Net Buying |
| PINE | ALPINE INCOME PROPERTY TRUST INC | United States | $203.39M | 13,623,239 | 56.52% | 8.92% | Net Buying | Net Buying |
| LW | LAMB WESTON HOLDINGS INC | United States | $12.11B | 144,391,021 | 89.18% | 1.05% | Net Selling | Net Buying |
| AEYE | AUDIOEYE INC | United States | $167.13M | 11,695,373 | 7.23% | 86.13% | Net Buying | Net Selling |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | United States | $2.71B | 63,886,757 | 72.47% | 27.53% | Net Buying | Net Selling |
| ATNM | ACTINIUM PHARMACEUTICALS INC | United States | $204.61M | 29,783,451 | 15.63% | 84.37% | ||
| NTES | NETEASE INC | China | $61.64B | 3,210,783,141 | 2.22% | 0.00% | ||
| MSTR | MICROSTRATEGY INC | United States | $21.76B | 16,968,125 | 47.95% | 0.65% | Net Selling | Net Selling |
| CRGX | CARGO THERAPEUTICS INC | United States | $735.30M | 39,363,052 | 71.34% | 28.66% | Net Buying | |
| IHS | IHS HOLDING LTD | United Kingdom | $1.17B | 331,920,002 | 14.21% | 0.00% | ||
| BHVN | BIOHAVEN LTD | United States | $3.18B | 81,579,914 | 79.08% | 20.92% | Net Buying | Net Buying |
| PYXS | PYXIS ONCOLOGY INC | United States | $249.97M | 58,133,375 | 15.13% | 36.17% | Net Selling | |
| DBRG | DIGITALBRIDGE GROUP INC | United States | $2.74B | 163,469,517 | 88.56% | 11.44% | Net Selling | Net Selling |
| SLN | SILENCE THERAPEUTICS PLC | United Kingdom | $855.04M | 118,846,966 | 17.28% | 0.00% | ||
| CRMD | CORMEDIX INC | United States | $291.95M | 54,981,102 | 34.05% | 10.98% | Net Buying | Net Buying |
| MRVI | MARAVAI LIFESCIENCES HOLDINGS INC | United States | $1.94B | 251,399,871 | 35.06% | 64.94% | Net Selling | Net Selling |
| UNCY | UNICYCIVE THERAPEUTICS INC | United States | $35.80M | 34,756,436 | 37.49% | 18.00% | ||
| LBTYA | LIBERTY GLOBAL LTD | United Kingdom | $6.17B | 377,546,627 | 82.91% | 13.82% | Net Selling | Net Selling |
| NAMS | NEWAMSTERDAM PHARMA CO NV | Netherlands | $1.96B | 89,266,673 | 60.05% | 39.95% | Net Selling | Net Selling |
| TTGT | TECHTARGET INC | United States | $785.03M | 28,546,634 | 40.90% | 59.10% | Net Selling | Net Selling |
| LENZ | LENZ THERAPEUTICS INC | United States | $130.78M | 8,319,561 | 49.99% | 50.01% | Net Buying | Net Buying |
| MNMD | MIND MEDICINE (MINDMED) INC | Canada | $352.17M | 41,334,307 | 10.01% | 89.99% | Net Selling | Net Selling |
| VSTM | VERASTEM INC | United States | $237.27M | 25,295,495 | 25.42% | 74.58% | Net Selling | Net Selling |
| SLNO | SOLENO THERAPEUTICS INC | United States | $1.23B | 32,460,579 | 20.62% | 79.38% | Net Buying | Net Selling |
| PRGS | PROGRESS SOFTWARE CORP | United States | $2.18B | 43,218,086 | 83.38% | 16.62% | Net Selling | Net Selling |
| INAB | IN8BIO INC | United States | $45.02M | 43,287,325 | 19.83% | 52.04% | Net Buying | |
| CNOB | CONNECTONE BANCORP INC | United States | $702.79M | 38,404,043 | 60.01% | 39.99% | Net Selling | Net Selling |
| TNK | TEEKAY TANKERS LTD | Bermuda | $2.00B | 34,093,108 | 52.29% | 0.00% | ||
| DFLI | DRAGONFLY ENERGY HOLDINGS CORP | United States | $46.34M | 60,260,282 | 8.09% | 72.63% | ||
| CZR | CAESARS ENTERTAINMENT INC | United States | $7.92B | 216,299,768 | 78.37% | 21.63% | Net Selling | Net Selling |
| PMVP | PMV PHARMACEUTICALS INC | United States | $90.03M | 51,443,488 | 62.78% | 37.22% | Net Buying | |
| GPRE | GREEN PLAINS INC | United States | $1.38B | 64,264,356 | 54.71% | 45.29% | Net Buying | Net Buying |
| TSHA | TAYSHA GENE THERAPIES INC | United States | $446.97M | 187,018,275 | 69.58% | 15.93% | Net Buying | Net Selling |
| XNCR | XENCOR INC | United States | $1.22B | 61,120,272 | 66.74% | 33.26% | Net Buying | Net Selling |
| TCRX | TSCAN THERAPEUTICS INC | United States | $350.50M | 47,882,196 | 66.65% | 29.73% | Net Buying | |
| LXEO | LEXEO THERAPEUTICS INC | United States | $333.36M | 26,668,956 | 60.65% | 25.62% | Net Buying | |
| OTLK | OUTLOOK THERAPEUTICS INC | United States | $109.70M | 13,012,876 | 13.26% | 86.74% | Net Buying | Net Buying |
| CLDX | CELLDEX THERAPEUTICS INC | United States | $2.03B | 55,900,679 | 82.75% | 17.25% | Net Buying | Net Buying |
| ASTS | AST SPACEMOBILE INC | United States | $570.98M | 256,042,836 | 13.46% | 45.53% | Net Selling | Net Selling |
| CAR | AVIS BUDGET GROUP INC | United States | $3.57B | 35,472,745 | 33.29% | 66.71% | Net Selling | Net Selling |
| RZLT | REZOLUTE INC | United States | $105.40M | 39,625,271 | 21.83% | 78.17% | Net Buying | Net Buying |
| ACHV | ACHIEVE LIFE SCIENCES INC | United States | $157.90M | 34,251,911 | 7.96% | 27.78% | Net Buying | Net Selling |
| AVBP | ARRIVENT BIOPHARMA INC | United States | $471.97M | 30,567,768 | 0.00% | 34.25% | Net Buying | Net Buying |
| CRH | CRH PUBLIC LTD CO | Ireland | $54.23B | 690,357,372 | 62.43% | 0.00% | ||
| CALC | CALCIMEDICA INC | United States | $58.53M | 10,740,115 | 2.26% | 97.74% | Net Buying | Net Buying |
| BLTE | BELITE BIO INC | United States | $1.16B | 29,149,444 | 0.53% | 0.00% | ||
| IVVD | INVIVYD INC | United States | $256.33M | 119,221,230 | 37.84% | 62.16% | Net Selling | |
| LNTH | LANTHEUS HOLDINGS INC | United States | $4.49B | 68,525,556 | 53.56% | 46.44% | Net Selling | Net Selling |
| EYPT | EYEPOINT PHARMACEUTICALS INC | United States | $834.67M | 49,830,792 | 20.11% | 79.89% | Net Selling | Net Buying |
| ACLX | ARCELLX INC | United States | $2.74B | 52,796,618 | 44.19% | 55.81% | Net Selling | Net Selling |
| SLDB | SOLID BIOSCIENCES INC | United States | $339.06M | 37,756,877 | 21.64% | 78.36% | Net Buying | |
| PCVX | VAXCYTE INC | United States | $6.58B | 108,407,730 | 83.78% | 16.22% | Net Buying | Net Buying |
| TRML | TOURMALINE BIO INC | United States | $402.14M | 25,646,509 | 43.00% | 57.00% | Net Selling | |
| JBL | JABIL INC | United States | $14.26B | 120,597,316 | 64.87% | 35.13% | Net Selling | Net Selling |
| PRME | PRIME MEDICINE INC | United States | $530.73M | 119,939,247 | 32.55% | 67.45% | Net Buying | Net Buying |
| MXCT | MAXCYTE INC | United States | $386.32M | 104,128,650 | 62.67% | 11.15% | Net Buying | Net Buying |
| OLMA | OLEMA PHARMACEUTICALS INC | United States | $556.35M | 55,914,741 | 71.71% | 28.29% | Net Buying | Net Selling |
| ANNX | ANNEXON INC | United States | $423.12M | 90,025,573 | 76.31% | 23.69% | Net Buying | Net Selling |
| DAWN | DAY ONE BIOPHARMACEUTICALS INC | United States | $1.30B | 87,384,856 | 54.70% | 45.30% | Net Buying | Net Selling |
| GEF | GREIF INC | United States | $2.92B | 47,121,156 | 50.82% | 48.84% | Net Selling | Net Selling |
| FSBC | FIVE STAR BANCORP | United States | $377.44M | 17,353,369 | 46.05% | 49.88% | Net Buying | Net Buying |
| APTO | APTOSE BIOSCIENCES INC | Canada | $19.18M | 15,717,701 | 7.58% | 67.78% | Net Buying | |
| DCO | DUCOMMUN INC | United States | $789.74M | 14,641,154 | 86.85% | 9.96% | Net Selling | Net Selling |
| CMPS | COMPASS PATHWAYS PLC | United Kingdom | $509.97M | 64,227,371 | 35.78% | 53.62% | Net Selling | Net Selling |
| DNTH | DIANTHUS THERAPEUTICS INC | United States | $630.96M | 29,346,760 | 24.91% | 75.09% | Net Buying | |
| STRO | SUTRO BIOPHARMA INC | United States | $213.55M | 62,441,963 | 78.85% | 21.15% | Net Selling | Net Selling |
| SNDX | SYNDAX PHARMACEUTICALS INC | United States | $1.79B | 84,965,486 | 91.35% | 8.65% | Net Buying | Net Buying |
| ACDC | PROFRAC HOLDING CORP | United States | $1.31B | 159,594,192 | 12.73% | 80.30% | Net Buying | Net Buying |
| IMVT | IMMUNOVANT INC | United States | $3.95B | 145,292,970 | 44.83% | 55.17% | Net Buying | Net Selling |
| SVRA | SAVARA INC | United States | $609.23M | 138,148,141 | 32.26% | 67.74% | Net Buying | Net Selling |
| MYPS | PLAYSTUDIOS INC | United States | $305.11M | 136,208,564 | 27.59% | 42.85% | Net Selling | Net Selling |
| KC | KINGSOFT CLOUD HOLDINGS LTD | China | $754.17M | 3,562,097,466 | 0.95% | 0.00% | ||
| VYGR | VOYAGER THERAPEUTICS INC | United States | $413.77M | 54,300,627 | 47.14% | 52.86% | Net Selling | Net Selling |
| OMCL | OMNICELL INC | United States | $1.28B | 45,915,296 | 95.18% | 4.82% | Net Selling | Net Selling |
| ACRV | ACRIVON THERAPEUTICS INC | United States | $191.51M | 22,636,951 | 46.35% | 53.65% | Net Buying | Net Buying |
| IVA | INVENTIVA SA | France | $169.38M | 52,115,807 | 9.33% | 0.00% | ||
| MAG | MAG SILVER CORP | Canada | $1.33B | 102,972,650 | 38.42% | 0.00% | ||
| GM | GENERAL MOTORS CO | United States | $52.30B | 1,140,958,039 | 85.89% | 14.11% | Net Selling | Net Selling |
| STNG | SCORPIO TANKERS INC | Monaco | $3.86B | 53,107,765 | 56.90% | 0.00% | ||
| ADVM | ADVERUM BIOTECHNOLOGIES INC | United States | $190.74M | 20,754,915 | 72.30% | 27.70% | Net Buying | Net Buying |
| NOTE | FISCALNOTE HOLDINGS INC | United States | $179.48M | 131,009,719 | 35.02% | 64.98% | Net Selling | Net Selling |
| NR | NEWPARK RESOURCES INC | United States | $619.42M | 85,201,652 | 80.86% | 12.01% | Net Selling | |
| DAL | DELTA AIR LINES INC | United States | $32.21B | 645,312,283 | 69.12% | 0.38% | Net Selling | Net Selling |
| SYNA | SYNAPTICS INC | United States | $3.51B | 39,303,612 | 93.47% | 5.04% | Net Selling | Net Selling |
| BIP | BROOKFIELD INFRASTRUCTURE PARTNERS LP | Bermuda | $12.52B | 461,343,972 | 57.49% | 0.00% | ||
| TNGX | TANGO THERAPEUTICS INC | United States | $793.98M | 106,718,315 | 59.42% | 40.58% | Net Buying | Net Selling |
| ANRO | ALTO NEUROSCIENCE INC | United States | $381.21M | 26,883,988 | 0.00% | 24.97% | Net Buying | Net Buying |
| VLRS | CONTROLADORA VUELA COMPANIA DE AVIACION SAB DE CV | Mexico | $955.49M | 1,108,462,804 | 4.14% | 0.00% | ||
| DNLI | DENALI THERAPEUTICS INC | United States | $2.15B | 139,160,239 | 56.52% | 43.48% | Net Selling | Net Selling |
| VKTX | VIKING THERAPEUTICS INC | United States | $8.19B | 110,268,210 | 69.23% | 9.05% | Net Selling | Net Selling |
| HLVX | HILLEVAX INC | United States | $635.67M | 49,700,828 | 65.85% | 34.15% | Net Selling | Net Selling |
| ABUS | ARBUTUS BIOPHARMA CORP | Canada | $490.01M | 179,492,199 | 24.75% | 75.25% | Net Selling | Net Selling |
| RCUS | ARCUS BIOSCIENCES INC | United States | $1.41B | 90,864,829 | 48.32% | 51.68% | Net Buying | Net Selling |
| TNYA | TENAYA THERAPEUTICS INC | United States | $338.40M | 78,516,142 | 55.16% | 44.84% | Net Buying | Net Buying |
| MGX | METAGENOMI INC | United States | $282.17M | 37,472,351 | 0.00% | 32.96% | Net Buying | Net Buying |
| ACET | ADICET BIO INC | United States | $138.02M | 82,153,984 | 40.62% | 19.50% | Net Buying | |
| MGM | MGM RESORTS INTERNATIONAL | United States | $13.14B | 319,678,271 | 37.96% | 62.04% | Net Selling | Net Selling |
| OPK | OPKO HEALTH INC | United States | $878.21M | 696,991,667 | 17.43% | 82.57% | Net Buying | Net Buying |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.